• Über Taylor Wessing
  • Unsere Anwälte
  • Expertise
    • Branchen
        • Technologie-, Medien & Kommunikation
        • Private Wealth
        • Real Estate, Infrastructure & Energy
        • Life Sciences & Healthcare
        • Aerospace & Defence
        • Automobilindustrie & Mobilität
        • Business & Professional Services
        • Chemieindustrie
        • Konsumgüter und Einzelhandel
        • Bank- & Finanzwesen
        • Hotels, Hospitality & Leisure
        • Logistik & Transport
        • Industrieunternehmen
        • Öffentliche Dienste & Bildungsinfrastruktur
    • Rechtsgebiete
        • Künstliche Intelligenz
        • Bank- & Finanzrecht
        • Marken & Werbung
        • Handels- & Vertriebsrecht
        • Kartell-, Vergabe-, Beihilfe- und Außenhandelsrecht
        • Urheber- und Medienrecht
        • Wirtschaftsstrafrecht und Compliance
        • Gesellschaftsrecht/ M&A & Kapitalmärkte
        • Daten & Cybersicherheit
        • Disputes & Investigations
        • Arbeitsrecht
        • Umwelt, Planung & Regulierung
        • Environmental, Social & Governance (ESG)
        • Informationstechnologie
        • Notariat & Geschäftsgeheimnisse
        • Patents Technology & Life Sciences
        • Private Client
        • Private Equity
        • Projects, Energy & Infrastructure
        • Immobilienrecht
        • Regulation
        • Restrukturierung & Insolvenzrecht
        • Steuerrecht
        • Venture Capital
  • International
    • Europa
        • Standorte
        • Österreich
        • Belgien
        • Tschechische Republik
        • Frankreich
        • Deutschland
        • Ungarn
        • Italy
        • Niederlande
        • Polen
        • Portugal
        • Republik Irland
        • Slowakei
        • Spanien
        • Großbritannien
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German Group
        • Unsere Büros
    • Naher Osten & Afrika
        • Standorte
        • Naher Osten
        • Vereinigte Arabische Emirate
          Groups
        • Africa Group
        • Israel Group
        • Unsere Büros
    • Amerika
        • Standorte
        • Latein Amerika
        • USA
          Groups
        • Brazil Group
        • Unsere Büros
    • Asien
        • Standorte
        • Asien
        • China
        • Südkorea
          Groups
        • India Group
        • Japan Group
        • Unsere Büros
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • EU-Whistleblower-Richtlinie (HinSchG)
        • Lieferkettengesetz
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: Digitales Tech-Magazin
        • Podcasts
        • Synapse
        • Alle Insights
    • Events
        • In Präsenz
        • Online
        • Alle Events
    • News
        • Media Center
        • Unternehmensmeldungen
        • Deal Meldungen
        • Alle News
  • Karriere
  • DE
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • Team
  • Alison Dennis
Alison Dennis
Alison Dennis

Alison Dennis

Partner

  • London UK
+44 20 7300 4725
vCard
E-Mail Call me
Featured award

Legal 500 UK 2025

Leading partner

Scroll to featured award

Alison co-heads our international life sciences team. 

Alison is recognised as a top regulatory and transactional life science lawyer in Europe and is qualified in England & Wales and the Irish Republic. She works with mid-sized and large medical device and pharmaceutical manufacturers, helping them to design new product offerings to meet regulatory requirements and to facilitate product commercialisation across the UK and EU. Alison frequently negotiates optimal positions for pharma and medical device companies with regulators such as competent authorities, notified bodies, and industry bodies with voluntary codes.

Alison’s analytical understanding of strategy and business comes from over 25 years helping hundreds of life sciences companies manage the range of legal challenges that arise in putting medicinal products and medical devices on the market in Europe and beyond. Her experience has encompassed complex regulatory matters, corporate, competition, IP and compliance with anti-bribery laws and codes. She applies this breadth of knowledge to help companies achieve their business goals at the same time as regulatory and compliance requirements and she is consequently known for providing highly pragmatic advice.

Alison's recent experience includes advising:

  • For multiple medical devices and IVD clients, drafting Field Safety Notices and Field Safety Corrective Actions and negotiating these with regulators across many European countries, the Middle East and Asia: engaging with the TW products team in undertaking any consequential recall of products.
  • An international pharmaceutical company on responding to a PMCPA complaint and successfully appealing the decision.
  • A medical device company on an investigation of the activities of its sales and marketing teams in relation to engagements with HCPs and HCOs, undertaking the investigation and advising on changes to policies, processes, procedures and training.
  • A pharmaceutical company on gearing up with sales agreements and compliance activities, including extensive training, before placing their pharmaceutical product and their medical device on the market across Europe.
  • An IVD company on interactions with the MHRA and with government departments: steering a course to settle regulatory issues on a commercially acceptable basis.
  • On the VPAS scheme for pharmaceuticals, and regarding the size of the rebates payable under it.
  • Acting on the disposal of assets from an international manufacturer to a large medical device company, dealing with the issue of "frozen" MDD certificates and working with the notified body to facilitate the acquisition from a regulatory perspective.

Thomson Reuters, Stand-out Lawyers 2022 - Identified by in-house lawyers as one whom they rated above all others that they interact with.

Expertise

Rechtsgebiete und Gruppen

Daten & Cyber-Sicherheit
Urheber- und Medienrecht
Informationstechnologie
Patents Technology & Life Sciences
Marken & Werbung
Handels- & Vertriebsrecht
Kartell-, Vergabe-, Beihilfe- und Außenhandelsrecht
Wirtschaftsstrafrecht und Compliance
Disputes & Investigations
Regulation
Produktanforderungen
Produktsicherheit & Produkthaftung
Transport
EU-Recht & EU-Prozessrecht
Regulatorisches Gesundheitsrecht
Anti-Korruption
Regulatorische Beratung
Beilegung von Patent- & Know-how-Streitigkeiten
Erstellung & Verhandlung von Patent- & Know-how-Verträgen
Tech Litigation
Werbung & unlauterer Wettbewerb
Strategische Beratung der der Einführung von Produkten
Vertragsmanagement & Lokalisierung
Due Diligences
Verhandlung & Erstellung von B2B-Verträgen
Verhandlung & Erstellung von B2C-Verträgen
Regulatorische Rahmenbedingungen von Verträgen
Kooperationen & Joint Ventures
Vertriebskartellrecht
IP-bezogenes Kartellrecht
Compliance
Health Data
Prüfung neuer digitaler Geschäftsmodelle und Produkte
Regulatorische Beratung im Bereich Life Sciences

Branchen

Life Sciences & Healthcare
Real Estate, Infrastructure & Energy
Healthtech & Digital Health
Medizinprodukte
Real estate life sciences & healthcare
Biotechnologie
Health & social care and investors
Arzneimittel
Machine Learning

Advertising Medical Devices European Comparison Tool

Looking to promote your medical device products in Europe? Access our comparison tool to manage regulatory challenges across multiple jurisdictions. 

Access here

CV

Since 2020 Partner, Taylor Wessing
2008 - 2020 Partner & head of life sciences, Fieldfisher LLP
1996 - 2008 Associate to Partner, Reed Smith
1996 Admitted as a solicitor, England & Wales
1994 LPC, York Law School
1993 Masters, Law & Economics, University of Oxford (including Hamburg University & Erasmus University, Rotterdam)
1992 LLB (Hons) European Legal Studies, Law University of Bristol (including University of Rouen, France)

Karriere

Since 2020 Partner, Taylor Wessing
2008 - 2020 Partner & head of life sciences, Fieldfisher LLP
1996 - 2008 Associate to Partner, Reed Smith

Ausbildung

1996 Admitted as a solicitor, England & Wales
1994 LPC, York Law School
1993 Masters, Law & Economics, University of Oxford (including Hamburg University & Erasmus University, Rotterdam)
1992 LLB (Hons) European Legal Studies, Law University of Bristol (including University of Rouen, France)

Publikationen

Pharmaceutical Advertising 2022, Chambers Global Practice Guides, April 2022

Advertising medical devices in the EU – do the MDR and IVDR represent a change in EU law?, Journal of Medical Device Regulation, February 2020

Eudamed timelines: unravelling contradictory legislation to understand how the deadlines apply – a lawyer’s view, Medtech Insight, November 2019

The EU Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulations, Lexis PSL, November 2019

Distribution and marketing of drugs in England, Thomson Reuters Practical Law, November 2019

Distribution and marketing of drugs in the EU, Thomson Reuters Practical Law, November 2019

Commercialisation of healthcare in the EU, Thomson Reuters Practical Law, November 2019

Commercialisation of healthcare in England, Thomson Reuters Practical Law, November 2019

Complying on time with MDR/ IVDR: what options are open to those in trouble?, Medtech Insight, November 2018

Mitgliedschaften

Chair/vice-chair, legal & compliance committee, Association of British HealthTech Industries (ABHI), since 2013

Trustee and company secretary, Bede House Charity, 2008 - 2013

Regulatory Affairs Professional Society (RAPS)

The Organisation for Professionals in Regulatory Affairs (TOPRA)

 

Fremdsprachen

French

Awards

Legal 500 UK 2025

Featured

Leading partner

Managing Intellectual Property – IP Stars 2024

Patent and transactions star

Chambers and Partners UK 2024

Life Sciences regulatory - Band 2: “Alison Dennis is very experienced and an excellent lawyer.”

Chambers and Partners UK 2023

Life Sciences (transactional) - Band 3: Alison Dennis is called on by leading sector clients to advise them on all manner of high-value transactions and also on the compliance of their products with various regulatory regimes. She acts for market leaders in biotech, medical devices and pharmaceuticals. "Alison Dennis is very good on medical devices."

Mehr

Life Sciences (regulatory) - Band 2: Alison Dennis is called on by leading sector clients to advise them on all manner of high-value transactions and also on the compliance of their products with various regulatory regimes. She acts for market leaders in biotech, medical devices and pharmaceuticals. "Alison Dennis is very good on medical devices."

Alison has been recognised in The Lawyer's Hot 100 in 2022, for the second time, having been selected previously in the 2013 cohort.

Life Sciences - Transactional: "Alison Dennis is called on by leading sector clients to advise them on all manner of high-value transactions and also on the compliance of their products with various regulatory regimes. She acts for market leaders in biotech, medical devices and pharmaceuticals." "Alison Dennis has always been a knowledgeable and resourceful life science lawyer."

IP - contentious and non-contentious

Product liability - defendant

Product liability - defendant

News & Insights: Alison Dennis

Zu den Insights
Klicken Sie hier für Details
Life Sciences & Healthcare

Advertising skinny jabs – regulators react

12. Juni 2025

von Alison Dennis

Glass.Mapper.Sc.Fields.Image?.Alt
Life Sciences & Healthcare

Updated post-market surveillance (PMS) rules for medical devices in the UK: differences from the EU regulations

1. Mai 2025
In-depth analysis

von Alison Dennis und Alice Matthews

Klicken Sie hier für Details
Synapse - AI in Life Sciences

The regulation of clinical trials in which AI is deployed

While the AI Act is not applicable to certain research uses of AI, these exemptions do not apply to the use of AI in clinical trials, where a myriad of regulation and guidance has potential application.

6. März 2025
Quick read

von Alison Dennis und Dr. Manja Epping

2 von 10 Insights

Klicken Sie hier für Details
Zu den Insights

Aktuelle News & Insights

Aerospace & Defence

SAFE-Verordnung 2025 – Günstige Zinsen, schnelle Beschaffung?

13. Juni 2025
Quick read

von Dr. Michael Brüggemann und Johannes Schaadt-Wambach, LL.M. (Prag)

Klicken Sie hier für Details
Daten & Cyber-Sicherheit

Cybersecurity: Sophora Unternehmerkapital übernimmt mit Taylor Wessing die Data-Sec GmbH

13. Juni 2025

von mehreren Autoren

Klicken Sie hier für Details
Marken & Werbung

Bundesumweltamt untersagt deutschem Fernbusunternehmen die Werbung mit „klimafreundlich“ und „umweltneutral“ in Belgien

12. Juni 2025
Briefing

von Ina Kamps, M.A. und Andreas Bauer

Klicken Sie hier für Details
Immobilienrecht

The Procurement Act 2023: procurement challenges

12. Juni 2025
In-depth analysis

von Katie Chandler und Matt Evans

Klicken Sie hier für Details
Marken & Werbung

Bequemer Kauf auf Rechnung – Von Angeboten, Zahlungsmodalitäten und Informationspflichten

12. Juni 2025
Briefing

von Regina Kriebel, LL.M. (QMUL)

Klicken Sie hier für Details
Daten & Cyber-Sicherheit

Game, set and match! UK's Data (Use and Access) Bill passes

12. Juni 2025
Quick read

von Debbie Heywood

Klicken Sie hier für Details

Taylor Wessing im Handelsblatt Ranking 2025

12. Juni 2025

von Anika M Paul

Klicken Sie hier für Details
Private Equity

Advising in L'Oréal's acquisition of premium British skincare brand Medik8

11. Juni 2025

von mehreren Autoren

Klicken Sie hier für Details
Daten & Cyber-Sicherheit

Artikel 48 DSGVO – Neue EDSA-Leitlinien schaffen Klarheit bei Datenanfragen aus Drittstaaten

11. Juni 2025
Quick read

von Wiebke Reuter, LL.M. (London)

Klicken Sie hier für Details
UPC

What have we learned from two years UPC preliminary injunctions?

11. Juni 2025
In-depth analysis

von Geert Theuws

Klicken Sie hier für Details
Mehr

Weitere Beraterinnen und Berater

UK
Adrian Toutoungi

Adrian Toutoungi

Partner

Cambridge
+44 1223 446 420
E-Mail
Profil ansehen
Tasmina Goraya

Tasmina Goraya, PhD

Partner

Cambridge
+44 1223 446 431
E-Mail
Profil ansehen
Alle Beraterinnen und Berater

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.

Alle Events
Newsletter-Anmeldung
  • Über Taylor Wessing
  • Campaigns and online tools
  • News
  • Unsere Anwälte
  • Expertise
  • International
  • Insights
  • Events
  • Presse & News
  • Kontakt
  • Karriere
  • Alumni
  • Datenschutzhinweise
  • Datenschutzbestimmungen & Cookie Hinweise
  • Rechtliche und regulatorische informationen
  • Regulatorische Informationen zu Kosten
  • Beschwerdeverfahren für Mandanten
  • Nutzungsbedingungen
  • Anti-slavery Statement
  • Nachhaltigkeit
  • Scam E-Mails

© Taylor Wessing